Insider Trading & Executive Data
Start Free Trial
109 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
IonQ develops and commercializes trapped‑ion quantum computers, related networking products, and professional services, selling both cloud access (via AWS, Azure, Google and its own cloud) and dedicated hardware plus consulting to customers in pharma, chemicals, finance, logistics, government and research. The company emphasizes a modular trapped‑ion architecture and measures progress with an “algorithmic qubits” (#AQ) roadmap supported by a substantial patent portfolio and partnerships with cloud providers, national labs and strategic vendors. IonQ is in an early commercial scale‑up: revenue nearly doubled in 2024/2025 but the business remains loss‑making as R&D and commercialization investments accelerate and technical milestones (higher #AQ, lower error rates, photonic interconnects) drive the timetable to steadier, usage‑based revenue. Liquidity has been managed with equity financings, warrant and option exercises, and acquisitions that are expanding product and service breadth but also increase operating leverage and integration effort.
Compensation is heavily equity‑linked: stock‑based compensation is a material component of R&D and G&A expense (tens of millions annually) and the company has used equity grants for recruitment, retention and replacement awards tied to acquisitions. Management incentives are likely oriented to multi‑year technical and commercial milestones (e.g., #AQ, fidelity improvements, commercial deployments, recurring QCaaS usage and strategic partnerships) rather than short‑term GAAP profitability, given persistent losses and a roadmap focus. The 2024 disclosures show a notable one‑time CEO cash incentive and growing cash‑payroll spend, indicating a blend of cash and equity levers as hiring and retention needs intensify. Because IonQ relies on capital raises and option/warrant exercises for financing, compensation committees will balance dilution, grant size and vesting tied to measurable technical and revenue milestones.
Expect insider activity to reflect equity‑heavy pay and funding dynamics: executives and directors may exercise options or warrants to cover tax and liquidity needs and occasionally sell shares in connection with financings or ATM offerings, which has been a material source of cash historically. High stock volatility (including mark‑to‑market swings from public warrants) and milestone‑driven newsflow (technical updates, partnership/cloud contract announcements, acquisition closings) make timing of Form 4 filings and 10b5‑1 plans especially relevant for interpreting sales versus planned dispositions. Regulatory constraints are material: Section 16 reporting, typical blackout periods around quarterly results and possible export‑control or government‑contract confidentiality requirements can restrict trading windows; watch for clustered insider trades post‑earnings, post‑financings, or immediately following major technical demonstrations.